Cargando…
COVID-19 and the brain: impact on nuclear medicine in neurology
Autores principales: | Morbelli, Silvia, Ekmekcioglu, Ozgul, Barthel, Henryk, Albert, Nathalie L., Boellaard, Ronald, Cecchin, Diego, Guedj, Eric, Lammertsma, Adriaan A., Law, Ian, Penuelas, Ivan, Semah, Franck, Traub-Weidinger, Tatjana, van de Giessen, Elsmarieke, Varrone, Andrea, Garibotto, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375837/ https://www.ncbi.nlm.nih.gov/pubmed/32700058 http://dx.doi.org/10.1007/s00259-020-04965-x |
Ejemplares similares
-
EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2021) -
Correction to: EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2022) -
2-[(18)F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
por: Verger, Antoine, et al.
Publicado: (2022) -
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
por: Morbelli, Silvia, et al.
Publicado: (2020) -
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
por: Verger, Antoine, et al.
Publicado: (2023)